Yusuf Özkay

32PUBLICATIONS
24CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsBiomolecular modelling and designBiologically active moleculesChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Apr 27, 2026
Quinoline/thiazole compounds as selective acetylcholinesterase inhibitors: synthesis and biological assessment.

|Feb 27, 2026
Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New N-Heterocyclic Compounds as Aromatase Inhibitors.

Fatih Tok, Begüm Nurpelin Sağlık Özkan, Yusuf Özkay

|Oct 30, 2025
Structure-based design, synthesis, and biological activity evaluation of chalcone-piperazine derivatives as dual AChE and MAO B inhibitors.

Berkant Kurban, Begüm Nurpelin Sağlık Özkan, Derya Osmaniye

|Oct 13, 2025
Innovative Pyrazole-Thiazole-Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer Treatment.

Burak Kuzu, Derya Osmaniye, Abdullah Burak Karaduman

|Mar 24, 2025
New benzimidazole derivatives containing hydrazone group as anticancer agents: Inhibition of carbonic anhydrase IX and molecular docking studies.

Hayrani Eren Bostancı, Mehmet Taha Yıldız, Serkan Kapancık

|Jul 03, 2024
Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens.

Tuncay Söylemez, Zafer Asım Kaplancıklı, Derya Osmaniye

Pageof 6

Frequent Collaborators

30 joint publications

Zafer Asım Kaplancıklı

19 joint publications

Serkan Levent

16 joint publications

Derya Osmaniye

14 joint publications

Begüm Nurpelin Sağlık Özkan